As of September 2024, AstraZeneca Pharma India has a market cap of $2.03B. This makes AstraZeneca Pharma India the world's 5132th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.64B | -0.29% |
2023 | $1.65B | 67.62% |
2022 | $982.64M | 6.42% |
2021 | $923.36M | -32.93% |
2020 | $1.38B | 76.53% |
2019 | $779.82M | 80.26% |
2018 | $432.62M | 24.37% |
2017 | $347.84M | 26.00% |
2016 | $276.06M | -25.77% |
2015 | $371.92M | 45.04% |
2014 | $256.42M | 2.91% |
2013 | $249.18M | -36.37% |
2012 | $391.62M | 7.53% |
2011 | $364.19M | -7.15% |
2010 | $392.22M | 39.75% |
2009 | $280.65M | 91.32% |
2008 | $146.69M | -24.95% |
2007 | $195.46M | 9.73% |
2006 | $178.13M | 17.56% |
2005 | $151.53M | 48.32% |
2004 | $102.16M | 74.30% |
2003 | $58.61M | 175.56% |
2002 | $21.27M | - |